Notes
GLP-1 = glucagon-like-peptide-1
Reference
Medicines and Healthcare products Regulatory Agency (UK). GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update 12: 4-6, No. 11, Jun 2019. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/810191/June-2019-DSU-PDF.pdf
Rights and permissions
About this article
Cite this article
Diabetic ketoacidosis with GLP-1 receptor agonists, insulin. Reactions Weekly 1760, 1 (2019). https://doi.org/10.1007/s40278-019-64160-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-64160-9